MBX logo
MBX NASDAQ US

MBX Biosciences, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Sep 2024
$32.99
▲ +$0.70 (+2.17%)
Vol 602K
3
Quality Score
fail
Mkt Cap
$1.4B
ROE
-29.3%
D/E
0.00
Beta
2.12
52W
$5–$36

Wall Street Consensus

15 analysts · Apr 2026
5
Strong Buy
8
Buy
1
Hold
1
Sell
0
Strong Sell
86.7%
Buy Rating

Price Chart

Similar Stocks

AMLX
Amylyx Pharmaceuticals Inc
$1.3B
RAPP
Rapport Therapeutics Inc
$1.4B
HRMY
Harmony Biosciences Holdings Inc
P/E 11.6
$2.2B
TRVI
Trevi Therapeutics Inc
$1.6B
MAZE
Maze Therapeutics Inc
$2.0B
ATAI
AtaiBeckley Inc
$1.5B
HROW
Harrow Inc
$1.8B
SEPN
Septerna Inc
$1.2B

Earnings

Beat rate: 100.0%
Next Report May 11, 2026
EPS Estimate: $-0.59
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.59 — —
Dec 2025 $-0.62 $-0.49 +$0.13
Sep 2025 $-0.70 $-0.63 +$0.07
Jun 2025 $-0.77 $-0.58 +$0.19

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -31.3% -31.3% -31.3% -31.3% -29.3% -29.3%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 19.50 19.50 19.50 19.50 32.95 32.95

Key Ratios

ROA (TTM)
-28.1%
P/B
2.4
EPS (TTM)
$-3.39
52W High
$35.55
52W Low
$4.81
$4.81 52-Week Range $35.55

How does MBX compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

MBX AARD ACB ACRS ADIL

MBX valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
2.4
▲ 13% above peers (2.1)
vs Peers
vs Industry
Fair value
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

MBX profitability vs Pharmaceuticals peers

ROE
-29.3%
▲ 46% above peers (-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼ 0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-28.1%
▲ 25% above peers (-37.4%)
vs Peers
vs Industry
Below avg

MBX financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
33.0
▲ 881% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.1
▲ 126% above peers (0.9)
vs Peers
vs Industry
More volatile

MBX fundamentals radar

MBX Peer median Industry

MBX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MBX vs peers: key metrics

Latest News

The Kestra Director Who Built and Sold a Device Company Keeps Buying …
Nasdaq · Apr 04
MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. …
Nasdaq · Mar 26